Acta Med. 1999, 42: 123-125
https://doi.org/10.14712/18059694.2019.154
Anti-Inflammatory Triterpenoids from Mysterious Mushroom Ganoderma Lucidum and Their Potential Possibility in Modern Medicine
References
1. Asai R. Miracle Cure: Organic Germanium. New York: Japan Publications/Kodansha International via Harper and Row, 1980.
2. CM, Waring SC, O’Brien PC, Kurland LT, Kokmen E. Nonsteroidal antiinflammatory drug use and Alzheimer’s disease: a case-control study in Rochester, Minnesota, 1980 through 1984. Mayo Clin Proc 1998; 73:951-5.
<https://doi.org/10.4065/73.10.951>
3. JC, Gau BA, Welsh KA et al. Inverse association of anti-inflammatory treatments and Alzheimer’s disease: initial results of a co-twin control study. Neurology 1994; 44:227-32.
<https://doi.org/10.1212/WNL.44.2.227>
4. Buchannan PK, Hseu RS, Moncalvo JM (Eds.). Ganoderma: Systematics, Phytopathology and Pharmacology. Proceedings of Contributed Symposia 59 B, 5th International Mycological Congress, Vancouver, August 14-21, 1994.
5. Chang HM, But BPH. Pharmacology and Applications of Chinese Materia Medica. Vol 1 and 2, World Scientific, Singapore 1986 and 1987.
6. Chang ST, Buswell JA, Chiu SW (Eds.).Mushroom Biology and Mushroom Products. Chang ST, Buswell JA, Chiu SW (Eds.). Hong Kong: The Chinese University Press, 1993:267.
7. M, Stewart W, Kawas C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer’s disease. Neurology 1996; 46:A433.
8. RN, Cohen DL, Premkumar DR. Cellular aspects of the inflammatory response in Alzheimer’s disease. Neurodegeneration 1996; 5:497-503.
<https://doi.org/10.1006/neur.1996.0069>
9. K, Sone T, Watanabe J et al. Immunomodulator, LZ-8, prevents antibody production in mice. Int J Immunopharmacol 1991; 13:1109-15.
10. JM, Lin CC, Chiu HF, Yang JJ, Lee SG. Evaluation of the anti-inflammatory and liver- protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am J Chin Med 1993; 21:59-69.
<https://doi.org/10.1142/S0192415X9300008X>
11. LJ, Shiao MS. Separation of oxygenated triterpenoids from Ganoderma lucidum by high-performance liquid chromatography. J Chromatogr 1987; 410:195-200.
<https://doi.org/10.1016/S0021-9673(00)90048-7>
12. WS, Chan WC, Hew CS. Superoxide and traditional Chinese medicines. J Ethnopharmacol 1995; 45:165-71.
<https://doi.org/10.1016/0378-8741(95)01297-Q>
13. Matsumo K. The Mysterious Reishi Mushroom. Santa Barbara: Woodbridge Press Publ. Comp., 1979.
14. EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998; 33:371-8.
<https://doi.org/10.1016/S0531-5565(98)00013-8>
15. P, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer’s disease. Neurology 1992; 42:447-9.
<https://doi.org/10.1212/WNL.42.2.447>
16. Mizuno T. Oriental medicinal tradition of Ganoderma lucidum (Reishi) in China. In: Mizuno T, Kim B-K (Eds). Ganoderma lucidum. Seoul, Korea: Il-Yang Pharm Co. Ltd., 1996:101-6.
17. T, Nishijima M. Studies on fungal polysaccharides. XXXVII. Structur examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 1981; 29:3611-6.
<https://doi.org/10.1248/cpb.29.3611>
18. GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain. Neuroscience 1998; 87:319-24.
<https://doi.org/10.1016/S0306-4522(98)00218-8>
19. JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease. Neurology 1995; 45:51-5.
<https://doi.org/10.1212/WNL.45.1.51>
20. J. Inflammation as a pathogenic mechanism in Alzheimer’s disease. Arzneimittel-Forsch 1995; 45:439-42.
21. MF, Larson EB. What’s new in Alzheimer’s disease treatment? Reasons for optimism about future pharmacologic options. Postgrad Med 1999; 105:109-18.
<https://doi.org/10.3810/pgm.1999.01.500>
22. Stavinoha W, Satsangi N, Weintraub S. Study of the antiinflammatory efficacy of Ganoderma lucidum. In: Kim B-K, Kim YS (Eds.). Recent Advances in Ganoderm lucidum Research. Seoul: The Pharmaceutical Society of Korea, 1995; 3-7.
23. RT, Satsangi N, Stavinoha WB, Weintraub ST. Anti-inflammatory components of mushroom extract on SUPELCOSIL ABZ+Plus HPLC Columns. The Reporter 1995; 14(5):1-3.
24. K, Akagi M, Miyoshi K, Mio M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release. Agents Actions 1988; 23:153-6.
<https://doi.org/10.1007/BF02142526>
25. K, Mio M, Izushi K, Akagi M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions 1988; 23:157-60.
<https://doi.org/10.1007/BF02142527>
26. JR, Botting RM. Mechanism of action of antiinflammatory drugs. Int J Tissue React 1998; 20:3-15.
